Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 40

Sort by

Sort Order Select

Journal Articles

Circulating hematopoietic stem/progenitor cell subsets contribute to human hematopoietic homeostasis

Blood (2024) 143 (19): 1937–1952.

https://doi.org/10.1182/blood.2023022666

Published: 2024

Includes: Supplemental data

Journal Articles

Unveiling the Biological Role of Peripheral Blood Human Circulating Hematopoietic Stem and Progenitor Cells

Blood (2022) 140 (Supplement 1): 1977–1978.

https://doi.org/10.1182/blood-2022-163251

Published: 2022

Journal Articles

Treosulfan Therapeutic Drug Monitoring: Optimizing Conditioning Therapy in Pediatric Hematopoietic Stem Cell Transplantation

Francesco Delle Cave, Simona De Gregori, Sonia Bonanomi, Adriana Balduzzi, Natalia Maximova, Marco Rabusin, Maria Ester Bernardo, Sabrina Basso, Giovanna Giorgiani, Lauren Marguerite Kelly, Marco Zecca

Blood (2022) 140 (Supplement 1): 12854–12855.

https://doi.org/10.1182/blood-2022-164829

Published: 2022

Journal Articles

Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study

Blood (2022) 140 (14): 1635–1649.

https://doi.org/10.1182/blood.2022015506

Published: 2022

Includes: Supplemental data

Journal Articles

Hematopoietic stem cell transplantation for Wiskott-Aldrich syndrome: an EBMT Inborn Errors Working Party analysis

Blood (2022) 139 (13): 2066–2079.

https://doi.org/10.1182/blood.2021014687

Published: 2022

Includes: Supplemental data

Journal Articles

Hematopoietic Stem Cells Are Endowed with Erythroid Signature in Beta-Thalassemia

Maria Rosa Lidonnici, PhD, Giulia Chianella, Francesca Tiboni, Matteo Barcella, PhD, Ivan Merelli, PhD, Samantha Scaramuzza, PhD, Claudia Rossi, Stefania Crippa, PhD, Maria Ester Bernardo, MD PhD, Fabio Ciceri, MD, Alessandro Aiuti, MD PhD, Sarah Marktel, MD, Giuliana Ferrari, PhD

Blood (2020) 136 (Supplement 1): 31.

https://doi.org/10.1182/blood-2020-137426

Published: 2020

Journal Articles

Extensive Metabolic Correction of Hurler Disease By Hematopoietic Stem Cell-Based Gene Therapy: Preliminary Results from a Phase I/II Trial

Bernhard Gentner, MD, Maria Ester Bernardo, MD PhD, Francesca Tucci, MD, Erika Zonari, PhD, Francesca Fumagalli, MD, Silvia Pontesilli, MD, Serena Acquati, PhD, Paolo Silvani, MD, Fabio Ciceri, MD, Attilio Rovelli, MD, Giancarlo La Marca, PhD, Rossella Parini, MD, Silvia Gregori, PhD, Eugenio Montini, PhD, Luigi Naldini, MD PhD, Alessandro Aiuti, MD PhD

Blood (2019) 134 (Supplement_1): 607.

https://doi.org/10.1182/blood-2019-128805

Published: 2019

Journal Articles

Results of a Multicentre, Randomized, Controlled Open-Label Study on the Use of Anti-T-Lymphocyte Globulin (ATLG) and Rituximab for Immunomodulation of Graft-Versus-Host Disease (GvHD) and Graft Failure (GF) in Patients with Non-Malignant Disorders

Mattia Algeri, MD, Stefania Galimberti, PhD, Maria Ester Bernardo, MD PhD, Attilio Rovelli, MD, Marco Zecca, MD, Giorgio La Nasa, MD, Sarah Marktel, MD, Pietro Merli, MD, Alice Bertaina, MD PhD, Daria Pagliara, MD PhD, Emilia Boccieri, MD, Francesca Del Bufalo, MD, Stefania Gaspari, MD, Giulia Capitoli, Maria Grazia Valsecchi, PhD, Franco Locatelli, MD PhD

Blood (2019) 134 (Supplement_1): 3280.

https://doi.org/10.1182/blood-2019-128925

Published: 2019

Journal Articles

Lentiviral Hematopoietic Stem and Progenitor Cell Gene Therapy for Wiskott-Aldrich Syndrome (WAS): Up to 8 Years of Follow up in 17 Subjects Treated Since 2010

Blood (2019) 134 (Supplement_1): 3346.

https://doi.org/10.1182/blood-2019-124665

Published: 2019

Journal Articles

Busulfan/Fludarabine- or Treosulfan/Fludarabine-Based Conditioning Regimen in Patients with Wiskott-Aldrich Syndrome Given Allogeneic Hematopoietic Cell Transplantation — an EBMT Inborn Errors Working Party and Scetide Retrospective Analysis

Blood (2018) 132 (Supplement 1): 2175.

https://doi.org/10.1182/blood-2018-99-112394

Published: 2018

Journal Articles

Impairment in the Mesenchymal Bone-Marrow Niche of Beta-Thalassemia Patients and Association with Prolonged Iron Exposure

Stefania Crippa, PhD, Valeria Rossella, Biologist, Laura Silvestri, PhD, Annamaria Aprile, PhD, Samantha Scaramuzza, Silvia Rivis, maria Antonietta Avanzini, Marco Zecca, MD, Sarah Marktel, MD, Fabio Ciceri, MD, Alessandro Aiuti, MD, Giuliana Ferrari, PhD, Maria Ester Bernardo, MD PhD

Blood (2017) 130 (Supplement 1): 948.

https://doi.org/10.1182/blood.V130.Suppl_1.948.948

Published: 2017

Journal Articles

Long-Term Results on Outcome of Children with Hematological Malignancies Transplanted from an Unrelated Donor Enrolled in an Open Label, Randomized Trial Comparing Two Different Dosages of Rabbit Anti-Thymocyte Globulin

Franco Locatelli, MD, Maria Ester Bernardo, MD, Alice Bertaina, MD PhD, Carla Rognoni, PhD, Patrizia Comoli, MD, Attilio Rovelli, MD, Andrea Pession, MD PhD, Franca Fagioli, MD, Claudio Favre, MD, Edoardo Lanino, MD, Giovanna Giorgiani, MD, Pietro Merli, MD, Arcangelo Prete, MD, Marco Zecca, MD

Blood (2016) 128 (22): 1168.

https://doi.org/10.1182/blood.V128.22.1168.1168

Published: 2016

Journal Articles

Manufacturing of Mesenchymal Stromal Cells for the Treatment of Graft-Versus-Host Disease: A Survey within the European Society of Blood and Marrow Transplantation

Blood (2016) 128 (22): 3374.

https://doi.org/10.1182/blood.V128.22.3374.3374

Published: 2016

Journal Articles

Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience

Blood (2016) 128 (3): 440–448.

https://doi.org/10.1182/blood-2016-03-704015

Published: 2016

Journal Articles

γδ T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-αβ + /CD19 + lymphocytes

Irma Airoldi, Alice Bertaina, Ignazia Prigione, Alessia Zorzoli, Daria Pagliara, Claudia Cocco, Raffaella Meazza, Fabrizio Loiacono, Barbarella Lucarelli, Maria Ester Bernardo, Giulia Barbarito, Daniela Pende, Alessandro Moretta, Vito Pistoia, Lorenzo Moretta, Franco Locatelli

Blood (2015) 125 (15): 2349–2358.

https://doi.org/10.1182/blood-2014-09-599423

Published: 2015

Includes: Supplemental data

Journal Articles

HLA-haploidentical stem cell transplantation after removal of αβ + T and B cells in children with nonmalignant disorders

Blood (2014) 124 (5): 822–826.

https://doi.org/10.1182/blood-2014-03-563817

Published: 2014

Journal Articles

Removal Of Alpha/Beta+ T Cells and Of CD19+ B Cells From The Graft Translates Into Rapid Engraftment, Absence Of Visceral Graft-Versus-Host Disease and Low Transplant-Related Mortality In Children With Acute Leukemia Given HLA-Haploidentical Hematopoietic Stem Cell Transplantation

Blood (2013) 122 (21): 157.

https://doi.org/10.1182/blood.V122.21.157.157

Published: 2013

Journal Articles

HLA Haploidentical Stem Cell Transplantation After Removal of αβ + T Lymphocytes and B Lymphocytes Is an Effective Treatment for Children with Life-Threatening, Non-Malignant Disorders

Alice Bertaina, MD, Mariateresa Romano, MD, Sergio Rutella, MD PhD, Giuseppe Palumbo, MD, Daria Pagliara, MD, Stefano Ceccarelli, MD, Letizia P Brescia, MD, Giuseppina Li Pira, BSc, Francesca Cocca, MD, Maria Ester Bernardo, MD, Giuseppe M Milano, MD, Daniela Pende, PhD, Michela Falco, BSc, Lorenzo Moretta, MD, Franco Locatelli, MD, PhD

Blood (2012) 120 (21): 2018.

https://doi.org/10.1182/blood.V120.21.2018.2018

Published: 2012

Journal Articles

How I treat relapsed childhood acute lymphoblastic leukemia

Franco Locatelli, Martin Schrappe, Maria Ester Bernardo, Sergio Rutella

Blood (2012) 120 (14): 2807–2816.

https://doi.org/10.1182/blood-2012-02-265884

Published: 2012

Journal Articles

Allogeneic hematopoietic stem cell transplantation in thalassemia major: results of a reduced-toxicity conditioning regimen based on the use of treosulfan

Maria Ester Bernardo, Eugenia Piras, Adriana Vacca, Giovanna Giorgiani, Marco Zecca, Alice Bertaina, Daria Pagliara, Benedetta Contoli, Rita Maria Pinto, Giovanni Caocci, Angela Mastronuzzi, Giorgio La Nasa, Franco Locatelli

Blood (2012) 120 (2): 473–476.

https://doi.org/10.1182/blood-2012-04-423822

Published: 2012

NARROW

Circulating hematopoietic stem/progenitor cell subsets contribute to human hematopoietic homeostasis

Unveiling the Biological Role of Peripheral Blood Human Circulating Hematopoietic Stem and Progenitor Cells

Treosulfan Therapeutic Drug Monitoring: Optimizing Conditioning Therapy in Pediatric Hematopoietic Stem Cell Transplantation

Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study

Hematopoietic stem cell transplantation for Wiskott-Aldrich syndrome: an EBMT Inborn Errors Working Party analysis

Hematopoietic Stem Cells Are Endowed with Erythroid Signature in Beta-Thalassemia

Extensive Metabolic Correction of Hurler Disease By Hematopoietic Stem Cell-Based Gene Therapy: Preliminary Results from a Phase I/II Trial

Results of a Multicentre, Randomized, Controlled Open-Label Study on the Use of Anti-T-Lymphocyte Globulin (ATLG) and Rituximab for Immunomodulation of Graft-Versus-Host Disease (GvHD) and Graft Failure (GF) in Patients with Non-Malignant Disorders

Lentiviral Hematopoietic Stem and Progenitor Cell Gene Therapy for Wiskott-Aldrich Syndrome (WAS): Up to 8 Years of Follow up in 17 Subjects Treated Since 2010

Busulfan/Fludarabine- or Treosulfan/Fludarabine-Based Conditioning Regimen in Patients with Wiskott-Aldrich Syndrome Given Allogeneic Hematopoietic Cell Transplantation — an EBMT Inborn Errors Working Party and Scetide Retrospective Analysis

Impairment in the Mesenchymal Bone-Marrow Niche of Beta-Thalassemia Patients and Association with Prolonged Iron Exposure

Long-Term Results on Outcome of Children with Hematological Malignancies Transplanted from an Unrelated Donor Enrolled in an Open Label, Randomized Trial Comparing Two Different Dosages of Rabbit Anti-Thymocyte Globulin

Manufacturing of Mesenchymal Stromal Cells for the Treatment of Graft-Versus-Host Disease: A Survey within the European Society of Blood and Marrow Transplantation

Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience

γδ T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-αβ + /CD19 + lymphocytes

HLA-haploidentical stem cell transplantation after removal of αβ + T and B cells in children with nonmalignant disorders

Removal Of Alpha/Beta+ T Cells and Of CD19+ B Cells From The Graft Translates Into Rapid Engraftment, Absence Of Visceral Graft-Versus-Host Disease and Low Transplant-Related Mortality In Children With Acute Leukemia Given HLA-Haploidentical Hematopoietic Stem Cell Transplantation

HLA Haploidentical Stem Cell Transplantation After Removal of αβ + T Lymphocytes and B Lymphocytes Is an Effective Treatment for Children with Life-Threatening, Non-Malignant Disorders

How I treat relapsed childhood acute lymphoblastic leukemia

Allogeneic hematopoietic stem cell transplantation in thalassemia major: results of a reduced-toxicity conditioning regimen based on the use of treosulfan

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only